Global Iodine-124 Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

According to our (Global Info Research) latest study, the global Iodine-124 market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
In 2025, global Iodine-124 production was approximately 650 grams, with an average global market price of around $13,000 per gram. That year, total global production capacity for Iodine-124 reached approximately 950 grams. The industry's average gross profit margin stood at approximately 55%. Iodine-124 (^124I) is an artificial radioactive isotope of iodine, a halogen element with an atomic number of 53 and a mass number of 124. It is a positron-emitting radionuclide with a half-life of approximately 4.18 days (about 100.2 hours), decaying primarily through positron emission and electron capture into stable tellurium-124 (^124Te). Due to its relatively long PET imaging window, high-resolution imaging capability, and suitability for quantitative metabolic tracing, ^124I is mainly used in positron emission tomography (PET), radiopharmaceutical development, biodistribution studies, and evaluation of targeted therapies. Compared with commonly used fluorine-18 (^18F), ^124I provides a much longer half-life, making it suitable for tracking biological processes over extended periods and supporting applications in precision medicine and molecular imaging.
The upstream segment of the Iodine-124 industry chain primarily encompasses the supply of natural iodine resources, the preparation of high-purity iodine compounds, target material production, and the supply of nuclear reaction equipment. Natural iodine is mainly derived from seawater, underground brine, and iodine-bearing mineral resources; following purification, it is used to produce high-purity iodine compounds for radioisotope manufacturing. Commercially, ^124I is primarily produced via proton bombardment of tellurium-124 (^124Te) targets or tellurium-compound targets in a cyclotron, utilizing nuclear reactions such as ^124Te(p,n)^124I. Given the requirements for high-energy proton beams, high-purity target preparation, and rigorous radiochemical process control, the upstream sector presents significant technical barriers and is concentrated among institutions possessing medical cyclotrons and radionuclide production capabilities. The midstream segment involves the separation and purification of Iodine-124, radiochemical labeling, drug preparation, and quality control. The ^124I produced by the cyclotron undergoes chemical separation to remove target impurities and enhance radiochemical purity and specific activity; it is subsequently labeled with various biomolecules to form radiotracers for PET imaging. Typical applications currently include research involving ^124I-labeled antibodies, peptide drugs, and other targeting molecules to evaluate in vivo drug distribution, pharmacokinetics, and the expression of therapeutic targets. Due to its relatively long half-life, ^124I offers superior transportability compared to short-lived radionuclides, enabling a regional supply model, although it remains subject to radiopharmaceutical regulations and quality control standards. Downstream applications of Iodine-124 focus primarily on molecular imaging, tumor diagnosis, radiopharmaceutical R&D, and precision medicine research. Its most representative application is as a PET tracer for the long-term, dynamic monitoring of tumor target expression, antibody drug distribution, and biological metabolic processes. Additionally, as iodine participates in thyroid-related metabolic processes, ^124I is utilized in studies of thyroid function and the imaging analysis of related diseases. With the development of radiopharmaceutical-drug conjugates (RDCs), targeted radionuclide therapy (RPT), and precision theranostics, the demand for ^124I—characterized by a long imaging window and high quantitative capability—continues to rise.
With the rapid development of precision medicine and molecular imaging technologies, demand for PET tracers with longer imaging windows and quantitative imaging capabilities continues to increase. Iodine-124 (^124I), with a half-life of approximately 4.18 days, enables extended in vivo tracking compared with conventional short-lived PET radionuclides, making it particularly suitable for studying the biodistribution of antibodies, proteins, peptides, and other macromolecular drugs. As precision oncology, target expression analysis, and personalized treatment strategies advance, the value of ^124I in PET molecular imaging continues to grow.
In recent years, the rapid development of radiopharmaceutical conjugates (RDCs), targeted radionuclide therapy (RPT), and theranostics has increased demand for advanced diagnostic radionuclides. ^124I can be used to label antibodies, proteins, peptides, and other targeting molecules, enabling researchers to evaluate drug biodistribution, targeting efficiency, and metabolism during preclinical and clinical development. With the expansion of antibody-based therapies, radiopharmaceutical pipelines, and oncology targeting programs, ^124I is expected to experience sustained demand growth as an important PET tracer for drug development.
The production of ^124I primarily relies on medical cyclotrons, enriched tellurium-124 (^124Te) targets, and radiochemical separation technologies. In recent years, improvements in compact medical cyclotrons, automated synthesis modules, and GMP radiopharmaceutical production systems have enhanced ^124I production efficiency, purity, and supply reliability. Meanwhile, the increasing number of nuclear medicine centers and PET research facilities worldwide is providing stronger infrastructure support for ^124I applications. In the future, organizations with cyclotron capabilities, target production expertise, and advanced radiochemistry technologies will maintain competitive advantages in the supply chain.
Report Scope
This report is a detailed and comprehensive analysis for global Iodine-124 market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Iodine-124 market size and forecasts, in consumption value ($ Million), sales quantity (Gram), and average selling prices (US$/g), 2021-2032
Global Iodine-124 market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Gram), and average selling prices (US$/g), 2021-2032
Global Iodine-124 market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Gram), and average selling prices (US$/g), 2021-2032
Global Iodine-124 market shares of main players, shipments in revenue ($ Million), sales quantity (Gram), and ASP (US$/g), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Iodine-124
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Iodine-124 market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IBA - Radio Pharma Solutions, ROSATOM, Attralus, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Iodine-124 market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity:98%-99%
Purity:＞99%
Market segment by Product Form
Iodine-124 Solution
Iodine-124 Standard Source
Iodine-124 Solid Target
Market segment by Production Route
Proton Bombardment of Tellurium Targets
Antimony Target Reaction Method
Nuclear Reactor Production
Laboratory-scale Preparation
Market segment by Purity Grade
Research-grade Iodine-124
Pharmaceutical-grade Iodine-124
High-radiochemical-purity Iodine-124
Market segment by Application
Medical Imaging
Scientific Research
Major players covered
IBA - Radio Pharma Solutions
ROSATOM
Attralus
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Iodine-124 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Iodine-124, with price, sales quantity, revenue, and global market share of Iodine-124 from 2021 to 2026.
Chapter 3, the Iodine-124 competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Iodine-124 breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Iodine-124 market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Iodine-124.
Chapter 14 and 15, to describe Iodine-124 sales channel, distributors, customers, research findings and conclusion.